The cost of Pertzye can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Pertzye. As with all medications, ...
Pertzye (pancrelipase) is a brand-name drug that’s prescribed for a lack of pancreatic enzymes due to cystic fibrosis and other conditions in adults and children. Pertzye comes as a delayed-release ...
Pertzye (pancrelipase) is a prescription drug that’s used to treat exocrine pancreatic insufficiency (EPI). Pertzye’s cost may depend on factors such as your dosage, whether you have health insurance, ...
BETHLEHEM, PA--(Marketwired - July 12, 2017) - Digestive Care, Inc. (DCI) and its marketing partner to support the U.S. cystic fibrosis (CF) community, Chiesi, today announced U.S. Food and Drug ...
CARY, NC--(Marketwired - May 9, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty ...
PERTZYE (pancrelipase) 16,000units;57,500units;60,500units delayed-release capsules by DigestiveCare Digestive Care has received FDA approval for Pertzye (pancrelipase delayed-release capsules) for ...
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, has entered into an agreement with Digestive Care ...
BETHLEHEM, PA--(Marketwired - July 14, 2017) - Digestive Care, Inc. (DCI) and its marketing partner to support the U.S. cystic fibrosis community, Chiesi, today announced U.S. Food and Drug ...
The Pertzye labeling describes the required steps for administering the 4,000 lipase units capsule through the G-tube. Only the contents of the 4,000 lipase units capsule should be used for G-tube ...
Pertzye (pancrelipase) is a prescription drug that’s prescribed to treat exocrine pancreatic insufficiency (EPI). The drug comes as a delayed-release capsule you swallow. It’s taken daily with each ...
BETHLEHEM, PA--(Marketwired - July 12, 2017) - Digestive Care, Inc. (DCI) and its marketing partner to support the U.S. cystic fibrosis (CF) community, Chiesi, today announced U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results